The opportunities and challenges of perioperative therapy of localized non-small cell lung cancer-thoughts from the KEYNOTE-671 trial
Transl Lung Cancer Res
.
2023 Nov 30;12(11):2347-2352.
doi: 10.21037/tlcr-23-570.
Epub 2023 Nov 14.
Authors
Nathaniel Deboever
1
,
Jianjun Zhang
2
Affiliations
1
Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
2
Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
PMID:
38090518
PMCID:
PMC10713268
DOI:
10.21037/tlcr-23-570
No abstract available
Keywords:
Non-small cell lung cancer (NSCLC); perioperative therapy; survival outcomes.
Publication types
Editorial
Comment
Grants and funding
R01 CA234629/CA/NCI NIH HHS/United States